BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19288003)

  • 21. A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity.
    Majumder S; Shah R; Elias J; Mistry Y; Coral K; Shah P; Maurya AK; Mittal B; D'Silva JK; Murugan S; Mahadevan L; Sathian R; Ramprasad VL; Chakraborty P; Gupta R; Chaudhuri A; Khanna-Gupta A
    PLoS One; 2018; 13(9):e0203845. PubMed ID: 30256815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology of the adenomatous polyposis coli tumor suppressor.
    Goss KH; Groden J
    J Clin Oncol; 2000 May; 18(9):1967-79. PubMed ID: 10784639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmoid Tumors in Familial Adenomatous Polyposis.
    DE Marchis ML; Tonelli F; Quaresmini D; Lovero D; Della-Morte D; Silvestris F; Guadagni F; Palmirotta R
    Anticancer Res; 2017 Jul; 37(7):3357-3366. PubMed ID: 28668823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cohorts with familial disposition for colon cancers in chemoprevention trials.
    Burt RW
    J Cell Biochem Suppl; 1996; 25():131-5. PubMed ID: 9027609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the non-steroidal anti-inflammatory drug sulindac on colorectal adenomas of uncolectomized familial adenomatous polyposis.
    Matsumoto T; Nakamura S; Esaki M; Yao T; Iida M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):251-7. PubMed ID: 16460482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
    Friedrich A; Kullmann F
    Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer.
    Telang N
    Oncol Lett; 2018 Jan; 15(1):642-648. PubMed ID: 29434827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.
    Hertervig E; Nilsson A; Nilbert M; Duan RD
    Int J Colorectal Dis; 2003 Jul; 18(4):309-13. PubMed ID: 12774245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
    Hu PJ; Knoepp SM; Wu R; Cho KR
    Genes Chromosomes Cancer; 2012 Mar; 51(3):283-9. PubMed ID: 22120905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apc mice: models, modifiers and mutants.
    McCart AE; Vickaryous NK; Silver A
    Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP).
    Bapat B; Berk T; Mitri A; Cohen Z; Gallinger S; Stern H
    Hum Mutat; 1994; 4(4):253-6. PubMed ID: 7866403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.
    Yedid N; Kalma Y; Malcov M; Amit A; Kariv R; Caspi M; Rosin-Arbesfeld R; Ben-Yosef D
    BMC Cancer; 2016 Dec; 16(1):952. PubMed ID: 28010732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
    Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
    Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of early-onset familial/hereditary colon cancer: new models and mechanistic biomarkers (review).
    Telang NT; Li G; Katdare M
    Int J Oncol; 2006 Jun; 28(6):1523-9. PubMed ID: 16685453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
    Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
    Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colon cancer prevention by detection of APC gene mutation in a family with attenuated familial adenomatous polyposis.
    Poovorawan K; Suksawatamnuay S; Sahakitrungruang C; Treeprasertsuk S; Wisedopas N; Komolmit P; Poovorawan Y
    Asian Pac J Cancer Prev; 2012; 13(10):5101-4. PubMed ID: 23244118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the adenomatous polyposis coli (APC) gene in Danish patients with familial adenomatous polyposis (FAP).
    Bisgaard ML; Ripa RS; Bülow S
    Hum Mutat; 2004 May; 23(5):522. PubMed ID: 15108286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype.
    Neklason DW; Solomon CH; Dalton AL; Kuwada SK; Burt RW
    Fam Cancer; 2004; 3(1):35-40. PubMed ID: 15131404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.